Can You Take Wegovy Every Two Weeks Instead of Weekly?

Why is Wegovy specifically once a week rather than every two weeks?

Semaglutide has a half-life of around one week, which is exactly why the once-weekly schedule works. Each injection maintains a relatively stable concentration in the body throughout the seven-day window. Stretch that to fourteen days and you are not just missing a dose, you are allowing active drug levels to fall to a point where the appetite and blood-sugar signalling effects fade substantially before the next injection arrives, which is why taking Wegovy every two weeks is not a recommended approach.

The clinical programme that established Wegovy's effectiveness used a fixed weekly schedule throughout. The STEP 1 trial, published in the New England Journal of Medicine, ran participants on 2.4mg once weekly for 68 weeks and recorded an average body-weight reduction of around 15%. That result depends on consistent weekly dosing. A fortnightly schedule was not tested and has no evidence base. Assuming the results would be similar at half the frequency is not a safe assumption to make.

The titration schedule adds another layer to this. Treatment starts at 0.25mg and moves up through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose, with roughly four weeks at each step. Disrupting the weekly rhythm during that escalation phase makes it harder for the body to adapt gradually, which is the whole point of titrating slowly in the first place.

What actually happens if you inject every two weeks instead?

Two things tend to happen, and neither is useful. First, effectiveness drops. Semaglutide's appetite-suppressing effect is dose- and concentration-dependent, so as levels trough between fortnightly injections, hunger signals return more strongly. Many people who have accidentally delayed a dose by even a few days report a noticeable uptick in appetite before the next injection, extending that gap to two weeks compounds it substantially.

Second, tolerability can worsen rather than improve. One reason people consider spacing out injections is to reduce nausea. But the GI side effects associated with semaglutide (nausea, indigestion, loose stools) are most pronounced during dose escalation and after gaps, when the body is effectively re-encountering the drug after a low-level period. A fortnightly pattern can recreate the conditions for side effects to recur at each injection, rather than the gradual settling that proper weekly dosing allows.

If you are tempted to stretch the schedule because of side effects or convenience, the guidance on Wegovy dosing frequency covers how to handle both scenarios properly. The short version: talk to your prescriber before changing anything.

What does a missed dose actually mean under the licensed guidance?

There is an important distinction between accidentally missing a dose and deliberately switching to an every-two-weeks pattern. The Patient Information Leaflet is specific: if you miss a dose and the next scheduled injection is still more than five days away, take the missed dose as soon as you remember. If your next scheduled injection is five days away or fewer, skip the missed one and carry on with the regular weekly schedule.

That five-day rule is the closest the approved guidance comes to acknowledging a longer gap, and it still assumes you return to weekly dosing immediately. It does not open a door to a permanent fortnightly routine. If you have lost track of your schedule this week, a quick check of the date on your last injection cap (something you can do in under a minute) tells you exactly which scenario you are in.

For anything beyond a single missed injection, contact your prescriber. At nume, our clinical team is reachable seven days a week via the aftercare line, so you are never left working this out alone.

Are there alternatives if the weekly routine feels unmanageable?

Yes, and they are worth raising rather than quietly adjusting your injection schedule. A few options are clinically supported. Slowing the titration pace (spending longer at a lower dose before moving up) can reduce side-effect burden without abandoning the weekly interval, and if you have been wondering whether taking Wegovy every other week might achieve the same effect, a prescriber can explain why adjusting titration pace is a safer route. That requires a prescriber to review and adjust your plan, which is exactly what a repeat consultation is for.

The other option that has changed significantly in 2026 is oral semaglutide. The MHRA approved Wegovy tablets in June 2026, making it the first oral GLP-1 licensed in the UK for weight management. The tablet is taken once daily rather than injected once weekly, and it requires no refrigeration. It is not right for everyone, but for people who dislike injections or struggle with the weekly routine, it is a legitimate clinical conversation to have. You can find a full overview of the treatment options available on the weight-loss treatment overview.

Eligibility for Wegovy in any form starts with a BMI assessment, and those who ask questions such as whether injecting every six days is acceptable are usually best served by a full prescriber review of their plan alongside the BMI criteria for Wegovy page, which covers the licensed thresholds and how they are applied in practice. These are prescription-only medicines, and every change (whether to dose, format or frequency) goes through a prescriber. That is not a bureaucratic hurdle; it is the safest way to get results that last.

If you would like a clinical review of your current plan or are considering starting treatment for the first time, speak to our prescribers through a free consultation.